Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1992 December; 85(12): 721–724.
PMCID: PMC1293756

Endogenous candida endophthalmitis.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (943K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Edwards JE, Jr, Foos RY, Montgomerie JZ, Guze LB. Ocular manifestations of Candida septicemia: review of seventy-six cases of hematogenous Candida endophthalmitis. Medicine (Baltimore) 1974 Jan;53(1):47–75. [PubMed]
  • Baley JE, Kliegman RM, Fanaroff AA. Disseminated fungal infections in very low-birth-weight infants: clinical manifestations and epidemiology. Pediatrics. 1984 Feb;73(2):144–152. [PubMed]
  • Griffin JR, Pettit TH, Fishman LS, Foos RY. Blood-borne Candida endophthalmitis. A clinical and pathologic study of 21 cases. Arch Ophthalmol. 1973 Jun;89(6):450–456. [PubMed]
  • Sorrell TC, Dunlop C, Collignon PJ, Harding JA. Exogenous ocular candidiasis associated with intravenous heroin abuse. Br J Ophthalmol. 1984 Nov;68(11):841–845. [PMC free article] [PubMed]
  • Servant JB, Dutton GN, Ong-Tone L, Barrie T, Davey C. Candidal endophthalmitis in Glaswegian heroin addicts: report of an epidemic. Trans Ophthalmol Soc U K. 1985;104(Pt 3):297–308. [PubMed]
  • Henderson DK, Hockey LJ, Vukalcic LJ, Edwards JE., Jr Effect of immunosuppression on the development of experimental hematogenous Candida endophthalmitis. Infect Immun. 1980 Feb;27(2):628–631. [PMC free article] [PubMed]
  • McDonald HR, De Bustros S, Sipperley JO. Vitrectomy for epiretinal membrane with Candida chorioretinitis. Ophthalmology. 1990 Apr;97(4):466–469. [PubMed]
  • Barrie T. The place of elective vitrectomy in the management of patients with Candida endophthalmitis. Graefes Arch Clin Exp Ophthalmol. 1987;225(2):107–113. [PubMed]
  • Brod RD, Flynn HW, Jr, Clarkson JG, Pflugfelder SC, Culbertson WW, Miller D. Endogenous Candida endophthalmitis. Management without intravenous amphotericin B. Ophthalmology. 1990 May;97(5):666–674. [PubMed]
  • O'Day DM, Head WS, Robinson RD, Stern WH, Freeman JM. Intraocular penetration of systemically administered antifungal agents. Curr Eye Res. 1985 Feb;4(2):131–134. [PubMed]
  • Savani DV, Perfect JR, Cobo LM, Durack DT. Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis. Antimicrob Agents Chemother. 1987 Jan;31(1):6–10. [PMC free article] [PubMed]
  • O'Day DM, Foulds G, Williams TE, Robinson RD, Allen RH, Head WS. Ocular uptake of fluconazole following oral administration. Arch Ophthalmol. 1990 Jul;108(7):1006–1008. [PubMed]
  • Stern GA, Fetkenhour CL, O'Grady RB. Intravitreal amphotericin B treatment of Candida endophthamitis. Arch Ophthalmol. 1977 Jan;95(1):89–93. [PubMed]
  • Graham E, Chignell AH, Eykyn S. Candida endophthalmitis: a complication of prolonged intravenous therapy and antibiotic treatment. J Infect. 1986 Sep;13(2):167–173. [PubMed]
  • Brooks RG. Prospective study of Candida endophthalmitis in hospitalized patients with candidemia. Arch Intern Med. 1989 Oct;149(10):2226–2228. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press